Gene Biotherapeutics (CRXM) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Gene Biotherapeutics Short Interest DataGene Biotherapeutics (CRXM) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Gene Biotherapeutics? Sign up to receive the latest short interest report for Gene Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCRXM Short Interest Over TimeCRXM Days to Cover Over TimeCRXM Percentage of Float Shorted Over Time Ad Stansberry Research2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisisDan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. Gene Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024100 shares $0.00 No ChangeN/A0 $0.00 9/30/2024100 shares $0.00 No ChangeN/A0 $0.00 9/15/2024100 shares $0.00 No ChangeN/A0 $0.00 8/31/2024100 shares $0.00 No ChangeN/A0 $0.00 8/15/2024100 shares $0.00 No ChangeN/A0 $0.00 7/31/2024100 shares $0.00 No ChangeN/A0.1 $0.00 Get the Latest News and Ratings for CRXM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gene Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024100 shares $0.00 No ChangeN/A0.3 $0.00 6/30/2024100 shares $0.00 No ChangeN/A0.5 $0.00 6/15/2024100 shares $0.00 No ChangeN/A0 $0.00 5/31/2024100 shares $0.00 No ChangeN/A0.1 $0.00 5/15/2024100 shares $0.00 No ChangeN/A0.1 $0.00 4/30/2024100 shares $0.00 No ChangeN/A1 $0.00 4/15/2024100 shares $0.00 No ChangeN/A0 $0.00 3/31/2024100 shares $0.00 No ChangeN/A0 $0.00 3/15/2024100 shares $0.00 No ChangeN/A0 $0.00 2/29/2024100 shares $0.00 No ChangeN/A0 $0.00 2/15/2024100 shares $0.00 No ChangeN/A1 $0.00 1/15/2024100 shares $0.00 No ChangeN/A0 $0.00 12/31/2023100 shares $0.00 No ChangeN/A0 $0.00 12/15/2023100 shares $0.00 No ChangeN/A0 $0.00 11/30/2023100 shares $0.00 No ChangeN/A0.2 $0.00 11/15/2023100 shares $0.00 No ChangeN/A0 $0.00 10/31/2023100 shares $0.00 No ChangeN/A0 $0.00 10/15/2023100 shares $0.00 No ChangeN/A0 $0.00 9/30/2023100 shares $0.00 No ChangeN/A1 $0.00 9/15/2023100 shares $0.00 No ChangeN/A0 $0.00 8/31/2023100 shares $0.00 No ChangeN/A49.5 $0.00 8/15/2023100 shares $0.00 No ChangeN/A1 $0.00 7/31/2023100 shares $0.00 No ChangeN/A0.1 $0.00 7/15/2023100 shares $0.00 No ChangeN/A0 $0.00 6/30/2023100 shares $0.00 No ChangeN/A0 $0.00 6/15/2023100 shares $0.00 No ChangeN/A0 $0.00 5/31/2023100 shares $0.00 No ChangeN/A1 $0.00 5/15/2023100 shares $0.00 No ChangeN/A0.5 $0.00 4/30/2023100 shares $0.00 No ChangeN/A0.1 $0.00 4/15/2023100 shares $0.00 No ChangeN/A0 $0.00 3/31/2023100 shares $0.00 No ChangeN/A1 $0.00 3/15/2023100 shares $0.00 No ChangeN/A0 $0.00 2/28/2023100 shares $0.00 No ChangeN/A0 $0.00 2/15/2023100 shares $0.00 No ChangeN/A1 $0.002025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. 1/31/2023100 shares $0.00 No ChangeN/A1 $0.00 1/15/2023100 shares $0.00 No ChangeN/A0 $0.00 12/30/2022100 shares $0.00 No ChangeN/A0 $0.00 12/15/2022100 shares $0.00 No ChangeN/A0 $0.00 11/30/2022100 shares $0.00 No ChangeN/A1 $0.00 11/15/2022100 shares $0.00 No ChangeN/A0 $0.00 10/31/2022100 shares $0.00 No ChangeN/A0 $0.00 10/15/2022100 shares $0.00 No ChangeN/A1 $0.00 9/30/2022100 shares $0.00 No ChangeN/A0 $0.00 9/15/2022100 shares $0.00 No ChangeN/A1 $0.00 8/31/2022100 shares $0.00 No ChangeN/A1 $0.00 8/15/2022100 shares $0.00 No ChangeN/A0.1 $0.00 7/31/2022100 shares $0.00 No ChangeN/A0.3 $0.00 7/15/2022100 shares $0.00 No ChangeN/A0 $0.00 6/30/2022100 shares $0.00 No ChangeN/A0.3 $0.00 6/15/2022100 shares $0.00 No ChangeN/A1 $0.00 5/31/2022100 shares $0.00 No ChangeN/A0 $0.00 5/15/2022100 shares $0.00 No ChangeN/A0 $0.00 4/30/2022100 shares $0.00 No ChangeN/A1 $0.00 4/15/2022100 shares $0.00 No ChangeN/A0.3 $0.00 3/31/2022100 shares $0.00 No ChangeN/A0 $0.00 3/15/2022100 shares $0.00 No ChangeN/A0.3 $0.00 2/28/2022100 shares $0.00 No ChangeN/A1 $0.00 2/15/2022100 shares $0.00 No ChangeN/A0 $0.00 1/31/2022100 shares $0.00 No ChangeN/A0 $0.00 1/15/2022100 shares $0.00 No ChangeN/A0 $0.00 12/31/2021100 shares $0.00 No ChangeN/A0.3 $0.00 12/15/2021100 shares $0.00 No ChangeN/A0 $0.00 11/30/2021100 shares $0.00 No ChangeN/A0.2 $0.00 11/15/2021100 shares $0.01 No ChangeN/A0 $0.00 10/29/2021100 shares $0.09 No ChangeN/A0 $0.00 10/15/2021100 shares $3.30 No ChangeN/A0 $0.03 9/30/2021100 shares $3.30 -99.4%N/A0 $0.03 9/15/202115,600 shares $600.60 -80.7%N/A0 $0.04 8/31/202180,600 shares $3,457.74 +406.9%N/A0.2 $0.04 8/13/202115,900 shares $704.37 -29.0%N/A0 $0.04 7/30/202122,400 shares $1,220.80 -36.4%N/A0 $0.05 7/15/202135,200 shares $1,760.00 +235.2%N/A0 $0.05 6/30/202110,500 shares $483.00 -70.8%N/A0 $0.05 6/15/202135,900 shares $1,787.82 -56.3%N/A0 $0.05 5/28/202182,100 shares $3,940.80 +269.8%N/A0.1 $0.05 5/14/202122,200 shares $1,110.00 +58.6%N/A0 $0.05 4/30/202114,000 shares $840.00 +241.5%N/A0 $0.06 4/15/20214,100 shares $164.00 -90.6%N/A0 $0.04 3/31/202143,700 shares $2,359.80 +43,600.0%N/A0 $0.05 3/15/2021100 shares $4.00 -99.9%N/A0 $0.04 2/26/202199,200 shares $4,464.00 +6.2%N/A0.1 $0.05 2/12/202193,400 shares $4,903.50 +613.0%N/A0.2 $0.05 1/29/202113,100 shares $524.00 +21.3%N/A0 $0.04 1/15/202145,500 shares $1,820.00 +135.8%N/A0.1 $0.042025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. 12/31/202015,200 shares $577.60 -66.6%N/A0 $0.04 12/15/202045,500 shares $1,820.00 +135.8%N/A0.1 $0.04 11/30/202019,300 shares $733.40 -16.1%N/A0 $0.04 11/15/202023,000 shares $1,207.50 +22,900.0%N/A0.1 $0.05 10/30/2020100 shares $6.05 -99.8%N/A0 $0.06 10/15/202050,200 shares $3,012.00 +241.5%N/A0.1 $0.06 9/30/202014,700 shares $918.75 -43.0%N/A0 $0.06 9/15/202025,800 shares $2,322.00 -48.0%N/A0 $0.09 8/31/202049,600 shares $3,224.00 +49,500.0%N/A0.1 $0.07 8/14/2020100 shares $7.25 -99.8%N/A0 $0.07 7/31/202062,300 shares $4,984.00 +74.5%N/A0.1 $0.08 7/15/202035,700 shares $3,002.37 -40.4%N/A0 $0.08 6/30/202059,900 shares $2,246.25 +57.6%N/A0.6 $0.04 6/15/202038,000 shares $1,520.00 +103.2%N/A0.2 $0.04 5/29/202018,700 shares $2,765.73 +12.0%N/A0.4 $0.15 5/15/202016,700 shares $2,474.94 +328.2%N/A1.1 $0.15 4/30/20203,900 shares $579.54 +3,800.0%N/A0.1 $0.15 4/15/2020100 shares $15.90 No ChangeN/A0 $0.16 3/31/2020100 shares $15.00 No ChangeN/A0 $0.15 3/13/2020100 shares $15.00 No ChangeN/A0 $0.15 2/28/2020100 shares $16.00 No ChangeN/A0 $0.16 2/14/2020100 shares $16.00 No ChangeN/A0.1 $0.16 1/31/2020100 shares $16.00 No ChangeN/A0 $0.16 1/15/2020100 shares $17.00 -50.0%N/A0 $0.17 12/31/2019200 shares $30.00 +100.0%N/A0 $0.15 CRXM Short Interest - Frequently Asked Questions What is Gene Biotherapeutics' current short interest? Short interest is the volume of Gene Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 100 shares of CRXM short. Learn More on Gene Biotherapeutics' current short interest. How does Gene Biotherapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Gene Biotherapeutics: Alvotech (0.08%), Amgen Inc. (2.08%), Gilead Sciences, Inc. (1.89%), argenx SE (3.25%), BioNTech SE (0.99%), Biogen Inc. (1.88%), Moderna, Inc. (11.90%), Neurocrine Biosciences, Inc. (3.86%), Bio-Techne Co. (2.57%), Vaxcyte, Inc. (8.85%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Gene Biotherapeutics stock? Short selling CRXM is an investing strategy that aims to generate trading profit from Gene Biotherapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gene Biotherapeutics? A short squeeze for Gene Biotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRXM, which in turn drives the price of the stock up even further. How often is Gene Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRXM, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies ALVO Short Squeeze QNNTF Short Squeeze AMGN Short Squeeze GILD Short Squeeze ARGX Short Squeeze BNTX Short Squeeze BIIB Short Squeeze MRNA Short Squeeze NBIX Short Squeeze TECH Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CRXM) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gene Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gene Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRXM Stock Alerts